Dôvera wants to pay doctors for collecting debts

PRIVATE health insurance company Dôvera encourages physicians in new addendums to contracts to inform non-payers of health insurance premiums on their debts or collect the arrears from them.

PRIVATE health insurance company Dôvera encourages physicians in new addendums to contracts to inform non-payers of health insurance premiums on their debts or collect the arrears from them.

Psychiatrist Kornélia Fabišíková of Moldava nad Bodvou told the Sme daily that she is not going to be a debt collector for an insurance company. She wrote about her objections to Dôvera’s step on her blog. The Pravda daily also informed about complaining doctors on October 19.

“It’s the abuse of the third party or intermediary and this form is always considered to be sort of pressure,” psychologist Karol Kleinmann told Pravda. “Insurance company should directly approach patient and should not abuse the third person, particularly doctors whom the patient depends upon, to collect fee.”

Dôvera promises a percentage of the debt to those who will cooperate with it in debt collection. Current average debt is €1,140; therefore, doctors could earn more than €11 per patient.

“This is just a possibility,” Dôvera’s head Martin Kultan told Sme, adding that if doctors do not inform patients about their debts and do not collect them it will not affect doctors’ agreements with insurance company.

(Source: Sme, Pravda)

Compiled by Roman Cuprik from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.

Get daily Slovak news directly to your inbox

Top stories

News digest: What Jankovská said and Kollár goes home amid scandal

Nationwide testing put on hold. Speaker of parliament received visitors in hospital despite a ban. Foreigners' Police change office hours around Christmas.

Speaker of Parliament Boris Kollár

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.